2406. “Real-world” Treatment of Multidrug-Resistant (MDR) or Extensively Drug-Resistant (XDR) P. aeruginosa Infections With Ceftolozane/Tazobactam (C/T) vs. a Polymyxin or Aminoglycoside (Poly/AG)-based Regimen: A Multicenter Comparative Effectiveness Study

BACKGROUND: The emergence of MDR/XDR P. aeruginosa has led to a reliance on suboptimal agents (Poly/AG) for the management of infections due to this pathogen. C/T is a novel agent with excellent in vitro activity against resistant P. aeruginosa that is indicated for cUTI and cIAI and being reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogue, Jason M, Kaye, Keith S, Veve, Michael, Gerlach, Anthony, Patel, Twisha S, Davis, Susan L, Chaung, Eugene, Ray, Amy, Puzniak, Laura, Bonomo, Robert A, Perez, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254523/
http://dx.doi.org/10.1093/ofid/ofy210.2059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254523/
http://dx.doi.org/10.1093/ofid/ofy210.2059

Ejemplares similares